Patent ID: 7217697

Claim:
A glucopyranosyloxypyrazole derivative represented by the general formula: wherein R 1 is a hydrogen atom or a hydroxy(C 2-6 alkyl) group; one of Q and T is a group represented by the general formula; the other is a C 1-6 alkyl group, a halo(C 1-6 alkyl) group, a C 1-6 alkoxy-substituted (C 1-6 alkyl) group or a C 3-7 cycloalkyl group; and R 2 is a halogen atom, a hydroxy group, a C 1-6 alkyl group, a C 1-6 alkoxy group, a C 1-6 alkylthio group, a halo(C 1-6 alkyl) group, a halo(C 1-6 alkoxy) group, a C 1-6 alkoxy-substituted (C 1-6 alkoxy) group, a C 3-7 cycloalkyl-substituted (C 2-6 alkoxy) group, or a group of the general formula: -A-R 3 wherein A is a single bond, an oxygen atom, a methylene group, an ethylene group, —OCH 2 — or —CH 2 O—; and R 3 is a C 3-7 cycloalkyl group, a C 3-7 heterocycloalkyl group, an aryl group which may have 1–3 the same or different substituents selected from a halogen atom, a hydroxy group, an amino group, a C 1-6 alkyl group, a C 1-6 alkoxy group, a C 2-6 alkenyloxy group, a halo(C 1-6 alkyl) group, a hydroxy(C 1-6 alkyl) group, a carboxy group, a C 2-7 alkoxycarbonyl group, a cyano group and a nitro group, a thiazolyl group which may have a substituent selected from a halogen atom and a C 1-6 alkyl group, or a pyridyl group which may have a substituent selected from a halogen atom and a C 1-6 alkyl group or a pharmaceutically acceptable salt thereof.